Hirasawa H - Search Results

1

Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients.

Nakada TA, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, Watanabe E, Abe R, Hatano M, Tokuhisa T. Nakada TA, et al. Among authors: hirasawa h. J Surg Res. 2005 Dec;129(2):322-8. doi: 10.1016/j.jss.2005.05.020. Epub 2005 Jul 27. J Surg Res. 2005. PMID: 16051275

2

[New anti-cytokine strategy against patients with hypercytokinemia stratified by cytokine-related genetic polymorphisms].

Watanabe E, Hirasawa H, Matsuda K. Watanabe E, et al. Among authors: hirasawa h. Nihon Rinsho. 2004 Dec;62(12):2317-22. Nihon Rinsho. 2004. PMID: 15597803 Japanese.

3

Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms.

Watanabe E, Hirasawa H, Oda S, Matsuda K, Hatano M, Tokuhisa T. Watanabe E, et al. Among authors: hirasawa h. Crit Care Med. 2005 Jan;33(1):89-97; discussion 242-3. doi: 10.1097/01.ccm.0000150025.79100.7d. Crit Care Med. 2005. PMID: 15644653

4

Watanabe E, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, Abe R, Nakada T. Watanabe E, et al. Among authors: hirasawa h. J Trauma. 2005 Nov;59(5):1181-9; discussion 1189-90. doi: 10.1097/00005373-200511000-00025. J Trauma. 2005. PMID: 16385298

5

Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients.

Abe R, Hirasawa H, Oda S, Sadahiro T, Nakamura M, Watanabe E, Nakada TA, Hatano M, Tokuhisa T. Abe R, et al. Among authors: hirasawa h. J Surg Res. 2008 Jun 1;147(1):1-8. doi: 10.1016/j.jss.2007.07.009. Epub 2007 Aug 20. J Surg Res. 2008. PMID: 17720196

6

Clinical application of cytokine-related gene polymorphism analysis using a newly developed DNA chip in critically ill patients.

Otani S, Oda S, Sadahiro T, Nakamura M, Watanabe E, Nakada TA, Abe R, Tokuhisa T, Hirasawa H. Otani S, et al. Among authors: hirasawa h. Clin Biochem. 2009 Sep;42(13-14):1387-93. doi: 10.1016/j.clinbiochem.2009.06.005. Epub 2009 Jun 13. Clin Biochem. 2009. PMID: 19527699

7

Outcome prediction in sepsis combined use of genetic polymorphisms - A study in Japanese population.

Shimada T, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, Abe R, Nakada TA, Tateishi Y, Otani S, Hirasawa H, Tokuhisa T, Uno H. Shimada T, et al. Among authors: hirasawa h. Cytokine. 2011 Apr;54(1):79-84. doi: 10.1016/j.cyto.2010.12.001. Epub 2011 Feb 1. Cytokine. 2011. PMID: 21282064

8

[Humoral mediators in the pathophysiology of organ dysfunction in sepsis].

Oda S, Hirasawa H, Shiga H, Matsuda K, Ueno H, Nakamura M, Watanabe E. Oda S, et al. Among authors: hirasawa h. Nihon Geka Gakkai Zasshi. 2003 Jul;104(7):511-7. Nihon Geka Gakkai Zasshi. 2003. PMID: 12884775 Japanese.

9

Modulation of polymorphonuclear leukocyte apoptosis in the critically ill by removal of cytokines with continuous hemodiafiltration.

Hirano T, Hirasawa H, Oda S, Shiga H, Nakanishi K, Matsuda K, Nakamura M, Asai T, Kitamura N. Hirano T, et al. Among authors: hirasawa h. Blood Purif. 2004;22(2):188-97. doi: 10.1159/000076852. Blood Purif. 2004. PMID: 15044817 Clinical Trial.

10

Catheter-related infections in continuous hemodiafiltration in intensive care patients.

Nakada TA, Hirasawa H, Oda S, Shiga H, Nakanishi K, Matsuda K, Nakamura M, Shima M, Watanabe M. Nakada TA, et al. Among authors: hirasawa h. Blood Purif. 2004;22(5):416-22. doi: 10.1159/000080233. Epub 2004 Aug 13. Blood Purif. 2004. PMID: 15316196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters